EV/EBITDA
-25.06
+1.23+4.68%
Mon, 06 Jan 2025 22:54:03 GMT
Summary:
Verona Pharma EV/EBITDA is currently -25.06, with a rise of +1.23 (+4.68%) during the most recent trading day. Over the past year, it has increased by +2.14 (+7.87%). VRNA EV/EBITDA is now -125400.00% below its all-time high of 0.02.VRNA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRNA EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +4.7% |
| 1 m1 month | -10.6% |
| 3 m3 months | -45.7% |
| 6 m6 months | -187.7% |
| ytdytd | +1.7% |
| 1 y1 year | +7.9% |
| 5 y5 years | -1857.8% |
VRNA EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -22.26 | -12.6% | -27.73 | +9.6% |
| 3 m | 3 months | -17.19 | -45.8% | -27.73 | +9.6% |
| 6 m | 6 months | -8.71 | -187.7% | -27.73 | +9.6% |
| 1 y | 1 year | -7.44 | -236.8% | -28.63 | +12.5% |
| 3 y | 3 years | -1.50 | -1570.7% | -31.39 | +20.2% |
| 5 y | 5 years | 0.02 | <-9999.0% | -31.39 | +20.2% |
| alltime | all time | 0.02 | <-9999.0% | -31.39 | +20.2% |
Verona Pharma EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -25.06(-1.7%) |
| 2024 | -25.49(-5.4%) |
| 2023 | -26.95(+5.4%) |
| 2022 | -25.56(+435.8%) |
| Date | Value |
|---|---|
| 2021 | -4.77(+37.5%) |
| 2020 | -3.47(+196.6%) |
| 2019 | -1.17(-63.3%) |
| 2018 | -3.19(-5.9%) |
| 2017 | -3.39 |
FAQ
- What is Verona Pharma EV/EBITDA?
- What is the all time high EV/EBITDA for Verona Pharma?
- What is VRNA EV/EBITDA year-to-date change?
- What is Verona Pharma EV/EBITDA year-on-year change?
What is Verona Pharma EV/EBITDA?
The current EV/EBITDA of VRNA is -25.06
What is the all time high EV/EBITDA for Verona Pharma?
Verona Pharma all-time high EV/EBITDA is 0.02
What is VRNA EV/EBITDA year-to-date change?
Verona Pharma EV/EBITDA has changed by +0.43 (+1.69%) since the beginning of the year
What is Verona Pharma EV/EBITDA year-on-year change?
Over the past year, VRNA EV/EBITDA has changed by +2.14 (+7.87%)